Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,934 | -57,705 | -32,581 | -49,963 | -38,759 |
| Depreciation Amortization | 950 | 880 | 918 | 1,045 | 1,140 |
| Accounts receivable | -106 | -38 | 98 | -101 | 126 |
| Accounts payable and accrued liabilities | 1,422 | 385 | -250 | 144 | -600 |
| Other Working Capital | 2,754 | -4,322 | 273 | -743 | 1,648 |
| Other Operating Activity | 1,933 | 24,069 | 2,765 | 1,251 | 101 |
| Operating Cash Flow | $-49,981 | $-36,731 | $-28,777 | $-48,367 | $-36,344 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -35,226 | -20,828 | 24,471 | 9,450 | -2,460 |
| PPE Investments | -114 | -147 | -771 | -380 | -252 |
| Net Acquisitions | N/A | N/A | N/A | 104 | N/A |
| Investing Cash Flow | $-35,340 | $-20,975 | $23,700 | $9,174 | $-2,712 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 82,540 | 29,914 | 20,703 | 21,675 | 26,069 |
| Other Financing Activity | 5,837 | 13,663 | 1,770 | 18,693 | 0 |
| Financing Cash Flow | $88,377 | $43,577 | $22,473 | $40,368 | $26,069 |
| Beginning Cash Position | 13,721 | 27,850 | 10,454 | 9,279 | 22,266 |
| End Cash Position | 16,777 | 13,721 | 27,850 | 10,454 | 9,279 |
| Net Cash Flow | $3,056 | $-14,129 | $17,396 | $1,175 | $-12,987 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,981 | -36,731 | -28,777 | -48,367 | -36,344 |
| Capital Expenditure | -114 | -147 | -771 | -380 | -252 |
| Free Cash Flow | -50,095 | -36,878 | -29,548 | -48,747 | -36,596 |